1. Bokemeyer C et al. J Clin Oncol 2014;32:(Suppl 4): abstr 3505. 2. Van Cutsem E et al. J Clin Oncol 2015;33(7):692-700. 3. Stintzing S et al. Oral presentation at the 2014 European Society for Medical Oncology Congress, September 26-30, 2014. Abstract No:LBA11. 4. Lenz H et al. Ann Oncol 2014;25(Suppl 5):v1-41. 5. National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology (NCCN Guidelines). Colon Cancer. Version 2.2016. Available from: http://www.nccn.org/patients. Accessed April 2016. 6. Van Cutsem E et al. Ann Oncol 2014;25(Suppl 3):iii 1-9. 7. Erbitux(R) (cetuximab) SmPC, Last updated Jun 2014. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_... . Accessed April 2016. 8. Vaughn CP et al. Genes Chromosomes Cancer 2011;50(5):307-12. 9. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013. Available from: http://globocan.iarc.fr . Accessed April 2016.
Gangolf Schrimpf
+49-6151-72-9591
Frankfurter Strasse 250
64293 Darmstadt . Germany
Hotline +49-6151-72-5000
http://www.merckgroup.com
Head Media Relations -62445
Spokesperson: -9591 / -7144 / -6328
Fax +49-6151-72-3138
media.relations@merckgroup.com
Photo:
http://photos.prnewswire.com/prnh/201512...